Lorillard
Topical Report NCI / S&Hp / Ornl Number 44 Site Visit Vi to Veteran's Administration Hospital East Orange, New Jersey, 770502 - 770503
Fields
- Author
- Gill, B.E.
- Jenkins, R.A.
- Quincy, R.B.
- Alias
- 89737699/89737714
- Type
- SCRT, SCIENTIFIC REPORT
- CHAR, CHART/GRAPH/MAPS
- TRIP, TRIP REPORT
- Area
- SPEARS,ALEXANDER/EXEC CONF ROOM STO
- Site
- G65
- Master ID
- 89737566/7894
- 89737566-7894 Annual Report Collection, Separation, and Elucidation of the Components of Cigarette Smoke and Cigarette Smoke Condensate Part I. Chemical Characterization of Experimental Cigarette Smokes Part II. Inhalation Bioassay Monitoring and Support Part III. Dosimetry and Bioimpact
- 89737577-7588 I. Chemical Characterization of Tobacco Smoke From Beagle Dog Inhalation Exposure Systems
- 89737589 II. Final Data - Series IV Cigarette Smoke and Condensate Chemical Analyses
- 89737590-7599 Topical Report NCI / S&Hp / Ornl Number 52 Final Smoke and Condensate Data for the Fourth Series of Experimental Varia Nts
- 89737600-7602 III. Chemical Analysis of Smokes of Foreign and Domestic Commercial Cigarettes
- 89737603-7606 Topical Report NCI / S&Hp / Ornl Number 49 Tar, Nicotine, Co and Co2 Deliveries of Philippine Cigarettes
- 89737607-7610 Topical Report NCI / S&Hp / Ornl Number 61 Tar, Nicotine, Co and Co2 Deliveries of Philippine Cigarettes
- 89737611-7614 Topical Report NCI / S&Hp / Ornl Number 66 Tar, Nicotine, Co and Co2 Deliveries of Italian Cigarettes
- 89737615-7621 Topical Report NCI / S&Hp / Ornl Number 51-A Chemical Analysis of Smoke From Second Set of Certain Domestic Commercial Low Tar and Nicotine Cigarettes
- 89737622-7624 Topical Report NCI / S&Hp / Ornl Number 53 Chemical Analysis of Smoke From Second Set of Certain Domestic Commercial Low Tar and Nicotine Cigarettes
- 89737625-7632 Topical Report NCI / S&Hp / Ornl Number 68 Chemical Analysis of Smoke From Selected South Florida Variants
- 89737633-7647 Topical Report NCI / S&Hp / Ornl Number 70 Chemical Analyses of Smoke From Selected Foreign Cigarettes United Kingdom, Uk Export, and Developing Nations
- 89737648-7649 IV. Swri Baboon Study Smoking Extremes Experiment
- 89737650-7655 Topical Report NCI / S&Hp / Ornl Number 58 Chemical Analysis of Smoke Delivered by Swri Baboon Study Cigarette Under Three Smoking Conditions
- 89737656-7661 V. Statistical Modeling of Histopathological Probabilities
- 89737669-7682 I. Monitoring of the Chronic Inhalation Exposures
- 89737683-7698 Topical Report NCI / S&Hp / Ornl Number 41 Site Visit I to Battelle Pacific Northwest Laboratories Rat Model Inhalatio N Bioassay Richland, Washington, 770223 - 770224
- 89737715-7729 Topical Report NCI / S&Hp / Ornl Number 46 Site Visit IV to Hazleton Laboratory Reston, Virginia, 770521 - 770522
- 89737730-7748 Topical Report NCI / S&Hp / Ornl Number 48 Site Visit I to Enviro Control Inc. Inhalation Laboratories Temple Hills, M Aryland, 770523 - 770525
- 89737749-7760 Topical Report NCI / S&Hp / Ornl Number 54 Site Visit Vii to Veteran's Administration Hospital East Orange, New Jersey, 770808 - 770809
- 89737761-7768 Topical Report NCI / S&Hp / Ornl Number 55 Intercomparison of Tobacco Smoke Dose Beagle Dog Inhalation Bioassays
- 89737769-7777 Topical Report NCI / S&Hp / Ornl Number 59 Inhalation Bioassay of Tobacco Smoke in Pigeons Site Visit I to Beth Israel Hospital (Bih) Boston Massachusetts, 771130 - 771201
- 89737778-7798 Topical Report NCI / S&Hp / Ornl Number 60 Site Visit II to Battelle Pacific Northwest Laboratories Rat Model Inhalati on Bioassay Richland, Washington, 770914 - 770915
- 89737799-7817 Topical Report NCI / S&Hp / Ornl Number 62 Site Visit II to Borriston Research Laboratories Temple Hills, Maryland, 77 1107 - 771109
- 89737818-7833 Topical Report NCI / S&Hp / Ornl Number 64 Site Visit V to Hazleton Laboratories Reston, Virginia, 771105 - 771106
- 89737834-7844 Topical Report NCI / S&Hp / Ornl Number 67 Site Visit I to the Hazleton Laboratories Cofactor Inhalation Bioassay Rest on, Virginia, 780223
- 89737845-7856 II. Instrumental Approaches to Bioassay Monitoring
- 89737857-7858 III. Trapping and Determination of Organic Gas Phase Constituents of Cigarette Smoke
- 89737859-7862 Trapping and Determination of Labile Compounds in the Gas Phase of Cigarette Smoke
- 89737863-7865 IV. Determination of Nitric Oxide and Nitrogen Dioxide in Cigarette Smoke by Chemiluminescent Analysis
- 89737868-7869 I. Brl - Ornl Collaborative Smoke Particulate Deposition Experiment
- 89737870-7876 II. C Tracer Studies to Develop Sampling Protocols for Quantitative Nicotine Dosimetry Following Smoke Exposure
- 89737877-7884 III. Isolation and Quantitative Analysis of Nicotine and Cotinine in Physiological Fluids
- 89737885-7894 IV. Physiological Fluids Studies: Mutagenicity and Profiling
Related Documents:
Document Images
Topical Report
NCI/S&HP/ORNL #44
SITE VISIT VI TO VETERAN'S ADMINISTRATION HOSPITAL
East Orange, New Jersey, May 2-3, 1977
7-20-77
B. E. Gill, R. B. Quincy, and R. A. Jenlcins
Tobacco Smoke Research Program
Bio/Organic Analysis Section
Analytical Chemistry Division
Oak Ridge National Laboratory
Oak Ridge, Tennessee 37830
Interagency Agreement (ERaA-NIH/NCI) No. 40-485-74, Part II
Internal (ORNL)<Contract Charge No. 3390-0224
Intended for informal communication with project management only.
Confidential until published or released by author.
,

SITE VISIT VI TO VAH
B. E. Gill, R. B. Quincy, and R. A. Jenkins
Summar . Data gathered on our sixth site visit to the Veteran's Admin-
istration Hospital, East Orange, NJ, indicate that the two animal groups
are being offered two distinctly different doses of nicotine, but iden-
tical total particulate matter doses. The magnitude of this dose is
similar 'to that in other NCI-sponsored inhalation studies. Preliminary
measurements of the carbon monoxide and carbon dioxide content of the
smoke reaching the cannula exit indicate that the smoke dose which the
animals receive is highly enriched in gas phase constituents. Detailed
chemical analysis of the particulate phase of the smoke of the LN
variant suggests that few particulate phase components are being se-
lectively enriched or depleted during passage through the exposure
devices.
Introduction. A sixth site visit was made to the Veteran's Administration
Hospital on May 2-3, 1977, to observe and document the beagle exposure
study which is being conducted there. As has been the case on previous
visits, our primary purpose was to collect data to enable us to better
estimate the dose which the animals receive and to determine the extent
to which certain smoking factors can contribute to the variability in
that dose. Both exposure and experimental details have been previously
discussed, and can be found in reports covering previous site visits
(Topical Reports NCI/S&HP/ORNL #6, 17, 18, 31, 32, and 38).
Experimental. In order to accomplish exposure definition, it has been
necessary to obtain information concerning both the physical operating
performance and smoke delivery performance of the ADL-I machines in
service. In addition, we are directing our monitoring effort toward a
more detailed chemical characterizatior of the smoke which the animals
are offered. Many samples'of smoke generated from the Code LN variant
(both ADL-I input and cannula exit samples) were returned and subjected
to a multi-component, multi-aliquot analysis. In this process, several

key components of the smoke are analyzed, usually via gas chromatography.
This permits a much more detailed chemical description of the particulate
phase of the smoke, as several of these components correlate highly with
the presence of entire classes of smoke constituents.
As mentioned in 'the "Preliminary Observations, Site Visit VI..."
(Topical Report #39), this was our first opportunity to sample, on site,
the cannula exit for carbon monoxide (CO) and carbon dioxide (C02). CO
is important because of its physiological impact, and the ratio of CO
and CO2 contents of the smoke give an indication of the pyrolysis con-
ditions in the burning cone of the cigarette. Briefly, the apparatus
for obtaining a gas phase sample from the cannula exit is similar to that
for a particulate phase sample, except that the effluent from the respir-
ator (ventilator) is expelled into a large, evacuated Saran gas-sampling
bag. Following completion of smoking, the contents of the bag are mixed
thoroughly, and a small portion is drawn into a small glass gas sampling
bulb. The bulb is then returned to ORNL for analysis, which is performed
by gas chromatography using Amberlyst ion exchange resin in the Ni-form
as the "stationary phase".
Results and Conclusions. Table I lists the measured puffing parameters
for the ADL-I machines in service at the time of our visit. In Ward 3,
puff volumes were significantly low. This is not manifested in lowered
smoke generation by those machines (see Table III). However, this effect
can be masked by high cigarette-to-cigarette variability (see below).
With the exception of Ward 3, when judged in terms of these puff parameter
measurements, the operation and reliability of the machines continue to
be adequate.
Table II compares the static burn rate (in weight of cigarette
burned per minute) of cigarettes smoked at VAH with that of those re-
turned to ORNL and smoked under analytical conditions. The HN variant
burns substantially faster, while the LN variant burns slightly faster
at VAFi. This is probably due to the ventilation air flow across the
cigarettes. Also, while on-site, we measured the relative humidity as
fluctuating between 39% and 65%. A lower relative humidity can contribute

to higher static burn rates, which, in turn, can act to reduce the
total amount of smoke generated by the machines.
The deliveries of total particulate matter (TPM) and nicotine of
cigarettes smoked on the ADL-I machines at VAH are tabulated individually
on Table III. Examination of the data indicates a rather large variation
in the amount of smoke generated for a given variant by the machines.
Table IV compares the amount of smoke generated on-site with that gen-
erated under analytical conditions (at three puffs per minute) at ORNL.
The data indicates that the exposure devices generate somewhat less
smoke on-site. A higher static burn rate could partially contribute to
this lowered delivery on-site by consuming more of the cigarette during
non-puffing fraction of the smoking cycle. The relative ratio of the
nicotine content of the smoke of the two variants is somewhat lower than
that observed analytically (2.6 vs 3.1). But the nicotine:TPM ratios
of both exposure and analytical smokes for a given variant are essentially
the same. This indicates that the smokes of the HN variant do not con-
tain differing amounts of nicotine, but rather that the machine-HN
variant combination produces less smoke on-site. Ultimately, this has
an effect on the differences in the nicotine doses which the animals
are offered.
Table V tabulates individually the TPM and nicotine outputs for
selected machines as sampled at the cannula exits. There is considerable
variation in the individual outputs, but the values are still more con-
sistent than those observed on site visits I-IV. Table VI compares the
average cannula exit values with the average input values (from Table
IV) for each of the two variants. About 50-60% of the smoke particulates
generated by the exposure devices are available for inhalation at the
cannula exit. The Teflon smoke delivery tubes of the ADL-I's were coated
with more condensed smoke than was the case for the previous visit (site
visit V), which probably contributed to the lowered particulate delivery
to the cannula exit. As discussed in previous Topical Reports (#32 and
#38), this depletion of particulates t1irough internal deposition probably
results in the animals being'offered a smoke which is relatively enriched
in gas phase constituents compared to the amount of particulate phase
present.

At the cannula exits, the relative ratio of the nicotine contents
of the smoke of the two variants drops to about 2.1 (from 2.6 at the
input to the exposure device). The data suggest that a lower efficiency
for the delivery of the smoke of the HN variant is the probable cause.
Ultimately, the most important chemical parameter of the inhalation
exposure is the dose which the animals receive. Our best estimate of
this is the amount of smoke which the animals are offered, as measured
at the cannula exit. Table VII lists our estimates of the smoke dose
per animal on a weekly basis for the two variants. The dose is only
slightly lower than that measured on the previous visit. In terms of
comparison with other NCI sponsored inhalation bioassays, the smoke dose,
as measured by the amount of particulates available for inhalation, is
very similar in magnitude. In this experiment, the two animal groups are
being offered two distinctly different amounts of nicotine, but identical
amounts of total particulates. This is the targeted dose.
In an effort to more exactly define the chemical composition of the
smoke which the animals are offered, we have been conducting more detailed
chemical characterization studies of the particulate samples acquired
on-site. Table VIII compares the chemistry of smoke samples of the LN
variant entering the exposure device with that of samples reaching the
cannula. With the exception of o-cresol, there appears to be little
change in the relative chemical composition of the particulate phase
as it passes through the exposure device, in terms of the measured com-
ponents. The o-cresol appears to have been selectively depleted, but
similar compounds (other cresols and phenol) do not exhibit this depletion.
This monitoring visit was our first opportunity to obtain samples
of gas phase constituents reaching the cannula exit of exposure systems
used in a chronic inhalation study. As mentioned in the preliminary ob-
servations (Topical Report #39), control samples taken prior to the trip,
carried to VAH, returned with the cannula exit samples and analyzed, gave
identical CO and COz values as samples remaining at ORNL. Table IX tab-
ulates the TPM, nicotine, CO and CQz vlalues obtained from eight cannula
exit samples of NN smoke retUrned to ORNL. The data indicates that, given
cigarette-to-cigarette variability, a given exposure device can be fairly
consistent in its output of both gas and particulate phases. In addition,

although there were widely differing particulate phase deliveries (two-
fold range) for the eight samples, the differences in the CO/CO2 outputs
are much smaller. This supports the hypothesis that gas phase delivery
of the exposure system will remain constant even with changes in the in-
ternal deposition of the particulates, effectively °'enriching" the smoke
in gas phase constituents.
Table X compares the average cannula exit values of the HN variant
with those obtained analytically. Code LN values are included for com-
parison. Two things should be noted. First, the CO:CO2 ratio of the
exposure smoke is significantly lower than that of smoke generated
analytically. Since a lower CO:CO2 ratio is often indicative of a
lowered effective puff volume through the cigarette, the data may suggest
that there are small air leaks around the butt of the cigarette where it
fits into the holder of the ADL-I. This would lower the fraction of the
35-m1 puff taken through the cigarette,and could at least partially con-
tribute to a lowered amount of particulates generated by the exposure
devices, and thus ultimately available at the cannula exit. Secondly,
the data verifies that little gas phase (using CO and C02 as indicator
compounds) is being lost in the machines. The data here indicates that
an animal is offered about 16 ml of CO and 45 rnl of C02 per cigarette.
Using the analytical data from Tables X and IV, one would predict a
dose (given the lower amount of nicotine generated on-site) of 20 ml
of CO and 45.5 ml of C02. The reduction in CO is probably a result of
a lower effective puff volume through the cigarette. Thus, based on this
preliminary data, at least for the HN variant, the animals are being
offered nearly all the gas phase constituents generated by the machine,
but only about half of the particulate phase.
e

Table I
Measured Puffing Parameters for ADL-I Smoking Machines
in Service at VAH on May 2-3, 1977
Cigarette Puff Period Puff Duration Puff Volume
Ward No. Code Machine No. (sec) (sec) (a,1)
1 NN 35 20 2.0 31.0
2 20 2.0 34.5
33 20 1.8 37.0
6 20 1.8 36.0
37 20 2.0 30.5
2 HN 19 20 1.8 35.5
7 20 2.0 36.5
3 20 1.8 37.0
15 20 1.8 36.0
14 20 2.0 37.5
3 HN 18 20 1.7 27.0
16 20 1.7 32.0
39 20 1.5 24.0
23 20 2.1 27.5
22 20 1.8 28.0
Mean Puff Volume for HN Machines 32.7 ± 4.4
4 LN 8 20 1.8 36.5
29 20 2.0 36.5
4 20 2.0 36.5
40 20 2.0 33.5
31 20 1.7 37.0
5 LN 25 20 2.0 35.0
13 20 2.0 35.5
28 20 2.0 35.5
1 20 2.0 36.0
17 20 2.0 31.0
6 LN 30 20 2.0 34.5
38 20 2.0 34.5
24 20 2.1 35.5
34 20 2.0 35.5
36 20 1.9 33.0
Mean Puff Volume for LN Machines 35.1 ± 1.6

Table II
Comparison of Cigarette Static Burn Rates
Exposure Conditions at VAH vs Analytical Smoking Conditions at ORNL
Cigarette Burn Ratea
Code Site mg/min
HNb VAH 89.9 ± 5.7
HN ORNL 67.1 ± 1.1
LNc VAH 80.3 ± 3.8
LN ORNL 73.8 ± 2.8
aBurn rate given in terms of actual weight of cigarette burned.
bMeasured in Wards 1, 2, and 3.
cMeasured in Wards 4 and 6.

Table III
Total Particulate Matter (TPM) and Nicotine Delivery of Cigarettes
Smoked on Selected ADL-I Smoking Machines in Service at VAH on
May 2-3, 1977
Ward No.
Cigarette Code
Machine No. TPM
mg/cig Nicotine
mg/cig Nicotine:TPM
Ratio
1 HN 2 34.5 2.69 .0780
33 39.1 3.24 .0829
6 61.1 4.39 .0718
37 46.4 3.53 .0761
35 64.8 4.33 .0668
Average 49.1 ± 13.3 3.63 ± 0.73 .0751 ± .0061
2 F{N 7 67.2 4.35 .0647
3 65.9 4.61 .0700
15 63.7 4.24 .0666
14 75.2 5.06 .0673
19 55.1 3.79 .0688
Average 65.4 ± 7.2 4.41 ± 0.47 .0675 ± .0020
3 HN 16 38.3 3.46 .0903
39 34.2 3.02 .0883
23 70.2 5.14 .0732
22 38.5 3.11 .0808
18 56.0 3.79 .0677
Average 47.4 ± 15.2 3.70 ± 0.86 .0801 ± .0097
4 LN 8 49.6 1.40 .0282
29 39.6 1.36 .0343
4 44.5 1.35 .0300
40 58.9 1.33 .0226
31 52.3 1.45 .0277
Average 49.0 ± 7.4 1.38 ± 0.05 .0286 ± .0042
5 LN 25 57.4 1.98 .0345
13 48.4 1.41 .0291
28 53.0 1.58 .0298
1 59.2 1.58 .0267
17 48.6 1.38 .0284
.
Average 53.3 ± 4.9 1.59 ± 0.24 .0297 ± .0029
6 LN 30 48.1 1.54 .0320 ~
38 52.0 1.50 .0288 ~
24 53.6 1.54 .0287 W
34 44.2 1.32 .0299 ~
36 54.1 1.47 .0272 p
Average
50.4
± 4.2
1.47 ± 0.09
.0293 ± .0018 a

Table IV
Comparison of Gigarette Deliveries: Input to ADL-I Smoking Machine at VAH
(Site Visit VI) vs Analytical Smoking Machine
Conditions
Cigarette Code
No. of Puffs
TPM, mg/cig
Nicotine, mg/cig Nicotine:TPM
Ratio
ADL-Ia HN 16.5 ± 1.0 54.0 ± 14.2 3.92 ± 0.75 .0742 ± .0082
Analyticalb HN 18.1 ± 0.8 72.3 ± 4.4 5.11 ± 0.35 .0707 ± .0027
ADL-Ia LN 16.6 ± 0.6 50.9 ± 5.6 1.49 ± 0.16 .0292 ± .0029
Analytica1b LN 17.2 ± 0.8 66.2 ± 2.7 1.66 ± 0.11 .0251 ± .0018
aValues given are overall averages for all input samples of a given code.
bAverage results for 8 cigarettes per code on the Phipps and Bird smoking machine
at 3 puffs per minute, 1 cigarette per pad.
